Diana Cortés‐Selva

Global effects of the <scp>DEAD</scp>‐box <scp>RNA</scp> helicase <scp>DeaD</scp> (<scp>CsdA</scp>) on gene expression over a broad range of temperatures

Christopher A. Vakulskas, Archana Pannuri, Diana Cortés‐Selva et al. · Molecular Microbiology · 2014 · 61 citations · Full text

Engineering, Genetics, Csrb/c Expression +17

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation

Kristine A. Frerichs, Christie P.M. Verkleij, María‐Victoria Mateos et al. · Blood Advances · 2023 · 60 citations · Full text

Humoral Response, Immunology, Immunoediting +16

Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Correlative Analyses from MajesTEC-1

Diana Cortés‐Selva, Tineke Casneuf, Deeksha Vishwamitra et al. · Blood · 2022 · 44 citations

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

Diana Cortés‐Selva, Tatiana Perova, Sheri Skerget et al. · Blood · 2024 · 37 citations · Full text

NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma

Christie P.M. Verkleij, Kristine A. Frerichs, Marloes E.C. Broekmans et al. · HemaSphere · 2023 · 32 citations · Full text